Tulane University

Tulane University to use artificial intelligence to study how nation’s schools are responding to coronavirus

The project will examine how students are learning when school buildings are closed.
24-Apr-2020 11:55 AM EDT, by Tulane University

Newswise — The U.S. Department of Education’s Institute of Education Sciences has awarded the National Center for Research on Education Access and Choice (REACH) at Tulane University a $100,000 contract to collect data from approximately 150,000 school websites across the country to see how the nation’s education system is responding to the coronavirus pandemic.

The project, which will track traditional public schools, charter schools and private schools, aims to quickly answer questions that are critical for understanding how students are learning when school buildings are closed. Key questions include: how many schools are providing any kind of instructional support; which are delivering online instruction; what resources are they offering to students and how do students stay in contact with teachers?

“This data will also help answer important questions about equity in the school system, showing how responses differ according to characteristics like spending levels, student demographics, internet access, and if there are differences based on whether it is a private, charter or traditional public school,” said REACH National Director Douglas N. Harris, Schlieder Foundation Chair in Public Education and chair of economics at Tulane University School of Liberal Arts.

REACH will work in cooperation with Nicholas Mattei, assistant professor of computer science at Tulane University School of Science and Engineering, to create a computer program that will collect data from every school and district website in the country. Due to the large volume and variety of data across the thousands of sites, the data will be analyzed using techniques from artificial intelligence (AI) and machine learning.

In addition, REACH will hire more than a dozen Tulane students to manually collect data from a random sample of around 3,600 school websites to inform the AI work with more in-depth, human analysis.

“Because of the urgency of the project, our aim is to release an initial summary of the results early this summer, in time to inform actions for the coming school year,” Harris said. “Once the initial analysis is complete, the data will be released to the public so that researchers, policymakers and journalists can study the different approaches that schools are taking and see which are more effective in helping students.”

The research project is an extension of a $10 million grant awarded to REACH in 2018 for research on school choice nationally.

 

ABOUT THE NATIONAL CENTER FOR RESEARCH ON EDUCATION ACCESS AND CHOICE: 

Founded in 2018, REACH provides objective, rigorous, and applicable research that informs and improves school choice policy design and implementation, to increase opportunities and outcomes for disadvantaged students. REACH is housed at Tulane University with an Executive Committee that includes researchers from Tulane, Michigan State University, Syracuse University, and the University of Southern California.



Filters close

Showing results

1120 of 5809
Released: 10-Jun-2021 4:05 PM EDT
Study Identifies How COVID-19 Linked to Alzheimer’s Disease-like Cognitive Impairment
Cleveland Clinic

A new Cleveland Clinic-led study has identified mechanisms by which COVID-19 can lead to Alzheimer’s disease-like dementia. The findings, published in Alzheimer's Research & Therapy, indicate an overlap between COVID-19 and brain changes common in Alzheimer’s, and may help inform risk management and therapeutic strategies for COVID-19-associated cognitive impairment.

Released: 10-Jun-2021 3:25 PM EDT
5 Leadership Strategies for Better Adapting in a Crisis
University of Maryland, Robert H. Smith School of Business

Maryland Smith management expert and futurist Oliver Schlake describes how companies can prepare for the next crisis as the economy gradually emerges from the COVID-19 pandemic.

7-Jun-2021 2:30 PM EDT
COVID-19 Creates Hearing, Balance Disorders, Aggravates Tinnitus Symptoms
Acoustical Society of America (ASA)

Evidence suggests auditory and vestibular effects should be added to the growing list of physiological impacts of COVID-19. During the 180th Meeting, Colleen Le Prell from the University of Texas at Dallas will talk about hearing and balance disorders associated with coronavirus infection and how pandemic-related stress and anxiety may aggravate tinnitus symptoms. Her presentation, "Hearing disorders secondary to infection with SARS-CoV-2," will take place Thursday, June 10.

Released: 10-Jun-2021 10:55 AM EDT
NCCN Cancer Experts Answer Questions about COVID-19 Vaccines
National Comprehensive Cancer Network® (NCCN®)

National Comprehensive Cancer Network’s patient information team provides a patient and caregiver version of recently-updated, evidence-based expert consensus recommendations for vaccinating people with cancer against COVID-19.

Newswise:Video Embedded doe-scientists-deploy-creativity-speed-to-disrupt-covid-19
VIDEO
Released: 10-Jun-2021 9:00 AM EDT
DOE scientists deploy creativity, speed to disrupt COVID-19
Oak Ridge National Laboratory

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.

Released: 10-Jun-2021 9:00 AM EDT
Warmer temperatures lessen COVID-19 spread, but control measures still needed
Imperial College London

New research shows transmission of the virus behind COVID-19 varies seasonally, but warmer conditions are not enough to prevent transmission.

8-Jun-2021 12:45 PM EDT
Monoclonal antibody therapy for COVID-19 safe, effective for transplant patients
Mayo Clinic

Treating transplant patients with mild to moderate cases of COVID-19 with monoclonal antibodies is safe and helps prevent serious illness, according to a Mayo Clinic study recently published in Open Forum Infectious Diseases. These results are especially important because transplant patients who are infected with COVID-19 have a higher risk of severe illness and death.

4-Jun-2021 2:25 PM EDT
Study Examines COVID-19 Among Patients Receiving Home Dialysis
American Society of Nephrology (ASN)

• Patients with kidney failure who are undergoing dialysis—whether at dialysis clinics or at home—face a higher risk of developing COVID-19 and a higher risk of dying from the disease.

4-Jun-2021 2:30 PM EDT
Immune Responses After COVID-19 Vaccination in Kidney Transplant Recipients and Patients on Dialysis
American Society of Nephrology (ASN)

• A large majority of patients with kidney failure on dialysis—but not kidney transplant recipients—developed antibody responses to SARS-CoV-2 after COVID-19 vaccination. • Vaccination also led to strong T cell responses against the virus that causes COVID-19 in all patients on dialysis, and in nearly 58% of kidney transplant recipients.

Newswise: New treatment demonstrated for people with vaccine clots
8-Jun-2021 10:50 AM EDT
New treatment demonstrated for people with vaccine clots
McMaster University

The treatment’s effectiveness was described in a report describing three Canadian patients who received the AstraZeneca vaccine, and who subsequently developed VITT. Two suffered clotting in their legs and the third had clots blocking arteries and veins inside their brain.


Showing results

1120 of 5809

close
2.83587